| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |